Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
- PMID: 33038973
- PMCID: PMC7544442
- DOI: 10.1016/S2213-2600(20)30451-3
Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
Comment on
-
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.Lancet Respir Med. 2020 Dec;8(12):1192-1200. doi: 10.1016/S2213-2600(20)30454-9. Epub 2020 Oct 8. Lancet Respir Med. 2020. PMID: 33038974 Free PMC article.
References
-
- Brendish NJ, Poole S, Naidu VV. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30454-9. published online Oct 8, 2020. - DOI - PMC - PubMed
-
- Liotti FM, Menchinelli G, Marchetti S. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Clin Microbiol Infect. 2020 https://dx.doi.org/10.1016%2Fj.cmi.2020.07.026 published online July 28. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
